NMT Medical pushes up StarFlex trial

September 16, 2009 by MassDevice staff

The Boston-based cardiac implant maker plans to begin analyzing trial data in April 2010, ahead of its fall target date, potentially setting the stage for a PMA application to the FDA in after the third quarter next year.

NMT Medical Inc. plans to begin analyzing the data from a clinical trial of its StarFlex cardiac implant ahead of schedule.

The Boston-based device maker said it will begin analyzing data from the CLOSURE I clinical trial of its StarFlex implant in April of next year, ahead of its fall 2010 target date.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.